B. Labrosse

发表

Impact of antiretroviral treatment on the tropism of HIV-1 plasma virus populations

V. Trouplin, F. Mammano, F. Clavel, 2003, AIDS.

A Genetically Engineered Waterfowl Influenza Virus with a Deletion in the Stalk of the Neuraminidase Has Increased Virulence for Chickens

D. Marc, T. Larcher, Y. Chérel, 2009, Journal of Virology.

Human immunodeficiency virus strains differ in their ability to infect CD4+ cells expressing the rat homolog of CXCR-4 (fusin)

O. Pleskoff, M. Alizon, B. Labrosse, 1997, Journal of virology.

Determinants for Sensitivity of Human Immunodeficiency Virus Coreceptor CXCR4 to the Bicyclam AMD3100

E. De Clercq, N. Heveker, D. Schols, 1998, Journal of Virology.

High level of susceptibility to human TRIM5α conferred by HIV-2 capsid sequences

F. Clavel, J. Takeuchi, F. Simon, 2013, Retrovirology.

Natural History of Sudan ebolavirus to Support Medical Countermeasure Development

J. P. Long, C. Sabourin, D. Wolfe, 2022, Vaccines.

WHO collaborative study to assess the suitability of an interim standard for antibodies to Ebola virus

E. Postnikova, R. Tedder, W. Hogrefe, 2016 .

Enhancement of the Influenza A Hemagglutinin (HA)-Mediated Cell-Cell Fusion and Virus Entry by the Viral Neuraminidase (NA)

S. Wurtzer, F. Clavel, S. van der Werf, 2009, PloS one.

Stability and antiviral activity against human cytomegalovirus of artemisinin derivatives.

N. Schnepf, F. Simon, B. Labrosse, 2014, The Journal of antimicrobial chemotherapy.

Resistance to a drug blocking human immunodeficiency virus type 1 entry (RPR103611) is conferred by mutations in gp41

C. Jones, O. Pleskoff, M. Alizon, 1997, Journal of virology.

Impact of Natural Polymorphism within the gp41 Cytoplasmic Tail of Human Immunodeficiency Virus Type 1 on the Intracellular Distribution of Envelope Glycoproteins and Viral Assembly

A. Moreau, P. Roingeard, B. Verrier, 2006, Journal of Virology.

Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma viruses

C. Charpentier, F. Mammano, F. Clavel, 2008 .

In vivo selection by enfuvirtide of HIV type-1 env quasispecies with optimal potential for phenotypic expression of HR1 mutations

F. Mammano, F. Clavel, A. Goubard, 2008, Antiviral therapy.

Sensitivity to a Nonpeptidic Compound (RPR103611) Blocking Human Immunodeficiency Virus Type 1 Env-Mediated Fusion Depends on Sequence and Accessibility of the gp41 Loop Region

M. Alizon, B. Labrosse, C. Tréboute, 2000, Journal of Virology.

Cooperation of the V1/V2 and V3 Domains of Human Immunodeficiency Virus Type 1 gp120 for Interaction with the CXCR4 Receptor

M. Alizon, A. Brelot, Anne Brelot, 2001, Journal of Virology.

Baseline Susceptibility of Primary Human Immunodeficiency Virus Type 1 to Entry Inhibitors

V. Trouplin, F. Mammano, F. Clavel, 2003, Journal of Virology.

Role of the Envelope Genetic Context in the Development of Enfuvirtide Resistance in Human Immunodeficiency Virus Type 1-Infected Patients

F. Mammano, F. Clavel, A. Hance, 2006, Journal of Virology.

Detection of Extensive Cross-Neutralization between Pandemic and Seasonal A/H1N1 Influenza Viruses Using a Pseudotype Neutralization Assay

R. Porcher, F. Clavel, J. Molina, 2010, PloS one.

Peptide P5 (residues 628–683), comprising the entire membrane proximal region of HIV-1 gp41 and its calcium-binding site, is a potent inhibitor of HIV-1 infection

M. Bomsel, F. Clavel, A. Alfsen, 2008, Retrovirology.

Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma viruses

C. Charpentier, F. Mammano, F. Clavel, 2008 .

Stability and antiviral activity against human cytomegalovirus of artemisinin derivatives.

N. Schnepf, F. Simon, B. Labrosse, 2014, The Journal of antimicrobial chemotherapy.